Skip to main content
. Author manuscript; available in PMC: 2020 Nov 1.
Published in final edited form as: Neuropharmacology. 2019 Apr 8;158:107597. doi: 10.1016/j.neuropharm.2019.04.003

Figure 3.

Figure 3.

Pharmacokinetic evaluation of R-VK4-40 following peri-oral administration in rats at 10 mg/kg. (A) Plasma and brain concentration vs time profile of R-VK4-40; data is expressed as mean ± SD, n=3, per time-point. (B) Mean ± SD pharmacokinetic parameters in plasma and brain. Brain to plasma ratio is calculated from mean total AUCbrain to AUCplasma.